Effects of potassium channel blockers on resting tone in isolated coronary arteries

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 636-642

  O'Rourke, Stephen T ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

4 Aminopyridine; Coronary arteries; Potassium channel blockers; Tetraethylammonium; Vascular smooth muscle

Indexed keywords

4 AMINOPYRIDINE; APAMIN; ATROPINE; CHARYBDOTOXIN; DILTIAZEM; GLIBENCLAMIDE; PHENTOLAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR RING;

4-AMINOPYRIDINE; ANIMALS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; POTASSIUM CHANNEL BLOCKERS; SWINE; TETRAETHYLAMMONIUM COMPOUNDS;

EID: 0029989254     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00004     Document Type: Article

References (41)

1. Hille B. Ionic channels of excitable membranes. Sunderland, MA: Sinauer Associates, 1992.
2. Benham CD, Bolton TB, Lang RJ, Takewaki T. Calcium-activated potassium channels in single smooth muscle cells of rabbit jejunum and guinea-pig mesenteric artery. J Physiol (Lond) 1986;371: 45-67.
3. Hume JR, LeBlanc N. Macroscopic K+ currents in single smooth muscle cells of the rabbit portal vein. J Physiol (Lond) 1989;413: 49-73.
4. + channels in arterial smooth muscle. Science 1989;245:177-80.
5. Luckoff A, Busse R. Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedeberg's Arch Pharmacol 1990;357:1-9.
6. Cooke JP, Rossitch E, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous vasodilator. J Clin Invest 1991;88:1663-71.
7. + channels contribute to vascular tone. Am J Physiol 1994;267: H1135-41.
8. Kirpekar SM, Wakade AR, Prat JC. Effect of tetraethylammonium and barium on the release of noradrenaline from the perfused cat spleen by nerve stimulation and potassium. Naunyn Schmiedebergs Arch Pharmacol 1976;294:23-9.
9. Hara Y, Kitamura K, Kuriyama H. Actions of 4-aminopyridine on vascular smooth muscle tissues of the guinea-pig. Br J Pharmacol 1980;68:99-106.
10. Illes P. Mechanisms of receptor-mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurones. Neuroscience 1986;17:909-28.
11. Hamilton TC, Weston AH. Cromakalim, nicorandil, and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 1989;20:1-9.
12. Iwaki M, Mizobuchi S, Nakaya Y, Kawano K, Niki T, Mori H. Tetraethylammonium induced coronary spasm in isolated perfused rabbit heart: a hypothesis for the mechanism of coronary spasm. Cardiovasc Res 1987;21:130-9.
13. Cook NS. Effect of some potassium channel blockers on contractile responses of the rabbit aorta. J Cardiovasc Pharmacol 1989; 13:299-306.
14. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992;256: 532-5.
15. Vanhoutte PM, Verbeuren TJ, Webb RC. Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 1981;61:151-247.
16. Pearson PJ, Vanhoutte PM. Vasodilator and vasoconstrictor substances produced by the endothelium. Rev Physiol Biochem Pharmacol 1993;122:1-67.
17. O'Rourke ST, Vanhoutte PM. Celiprolol has no direct or indirect relaxing effects in isolated arteries and veins. J Cardiovasc Pharmacol 1990;15:831-5.
18. Cohen RA, Shepherd JT, Vanhoutte PM. Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries. Circ Res 1983;52:16-25.
19. Van Rossum JM. Cumulative dose-response curves II. Techniques for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 1963; 143:299-330.
20. Johns RA, Linden JM, Peach MJ. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res 1989;65: 1508-15.
21. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989;257:H33-7.
22. 2. Am J Physiol 1989;257:H1327-33.
23. Kalsner S, Quillan M. Cholinergic contraction to field stimulation in coronary arteries of cattle. J Pharmacol Exp Ther 1989;249: 785-9.
24. +-channel blockers on transmitter release in bullfrog sympathetic ganglia. J Pharmacol Exp Ther 1985;235:241-7.
25. Cook NS, Quast U. Potassium channel pharmacology. In: Cook NS, ed. Potassium channels: structure, function and therapeutic potential. Chichester: Ellis Horwood, 1990:181-255.
26. + channels in canine renal artery. Novel mechanism for agonist-induced membrane depolarization. Circ Res 1995;77:121-30.
27. O'Rourke ST, Gross GJ. Glyburide selectively inhibits cromaklim-and pinacidil-induced relaxation of isolated pig coronary artery. FASEB J 1990;4:A332.
28. + channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. J Pharmacol Exp Ther 1991;259:526-34.
29. Cowan CL, Cohen RA. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers. J Pharmacol Exp Ther 1992;260:248-53.
30. Wei CM, Hu S, Miller VM, Burnett JC Jr. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun 1994;205:765-71.
31. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond) 1994;481:407-14.
32. 2+-activated K channel in coronary artery smooth muscle cells and its role in vasodilation. FEBS Lett 1989;255:281-4.
33. Wilde DW, Lee KS. Outward potassium currents in freshly isolated smooth muscle cell of dog coronary arteries. Circ Res 1989; 65:1718-34.
34. + channels from mammalian skeletal muscle. Nature 1985;313:316-8.
35. Gimenez-Gallego G, Navia NA, Rueben JP, Katz GM, Kaczorowski GJ, Garcia ML. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci USA 1988;85:3329-33.
36. Banks BEC. Brown C. Burgess GM. et al. Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature 1979;282:415-7.
37. + channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats. Br J Pharmacol 1993;108:214-22.
38. Sturgess NC, Ashford MLJ, Cook DL, Hales CN. The sulfonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985;2:474-5.
39. + channel in insulin-secreting cells. J Biol Chem 1987;262:15840-4.
40. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 1992;263:H399-404.
41. Yokoyama M, Henry PD. Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res 1979;45:479-86.